Millennium Laboratories this week released a saliva-based test that enables physicians to more accurately gauge a patient's reaction to painkillers before prescribing. The Millennium Pharmacogenetic Testing detects genetic variations that may affect the way a patient handles commonly-prescribed chronic pain medication.
"This novel testing provides insight into whether or not a patient will experience the anticipated effect of a prescribed medication or be at increased risk for additional side effects," said Howard Appel, president of Millennium Laboratories.
The testing will help physicians determine if the dosing and selection of certain drugs — including methadone, benzodiazepines and tricyclic antidepressants — should be modified to better suit the patient's tolerance level.
Iowa Patients Lack Treatment Options After Pain Clinic Shutters
New Hampshire Prescribing Fewer Painkillers for Inmates
"This novel testing provides insight into whether or not a patient will experience the anticipated effect of a prescribed medication or be at increased risk for additional side effects," said Howard Appel, president of Millennium Laboratories.
The testing will help physicians determine if the dosing and selection of certain drugs — including methadone, benzodiazepines and tricyclic antidepressants — should be modified to better suit the patient's tolerance level.
Related Articles on Pain Management:
8 New Pain Management Program Launches, Acquisitions or DevelopmentsIowa Patients Lack Treatment Options After Pain Clinic Shutters
New Hampshire Prescribing Fewer Painkillers for Inmates